Industry Experts, March 2011, Pages: 264
.2.5.4 Data Integration
1.2.5.5 Analysis of Integrated Data
1.2.6 Software and Tools
1.2.6.1 Web Services in Bioinformatics
1.3 APPLICATION ANALYSIS
1.3.1 Genomics
1.3.2 Proteomics
1.3.3 Transcriptiomics
1
Decision Resources, Inc., Nov 2011
-term stopgap for fixing this crisis?
- When Pfizer acquired Wyeth Pharmaceuticals in 2009, the combined R&D spend of the two companies was about $11 billion. In 2012, Pfizer plans to invest only
Decision Resources, Inc., Dec 2008, Pages: 35
manifest in a variety of biomarker centered partnerships that involved pharmaceutical and biotech companies, academic institutions, and government agencies and in several significant M&As that we examine
Axis Research Mind, Nov 2011, Pages: 342
science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more
Axis Research Mind, Feb 2011, Pages: 599
investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs), government organizations and many more in preferred locations. The report
Takeda Pacific, July 2008, Pages: 175
Myriad Genetics, Inc.
Nanogen, Inc.
Nanosphere, Inc.
Nymox Pharmaceutical Corporation
Orion Genomics LLC
Quest Diagnostics, Inc.
Roche Molecular Diagnostics
Sequenom, Inc.
Siemens Healthcare
Axis Research Mind, Nov 2011, Pages: 730
regions provides strategic business intelligence for life science and as well as healthcare sector investments. The study offers profitable investment strategies for R&D organizations, pharmaceutical
Frost & Sullivan, July 2009, Pages: 54
This research service presents the CEO 360 Degree Perspective for the global pharmaceuticals and biotechnology industry in 2009. It is an amalgamation of research from more than 50 Pharmaceutical
GBI Research, May 2010, Pages: 82
experts.
Declining ROI on R&D Investment is Among the Biggest Concerns in the Current Pharmaceutical Industry
While R&D (Research and Development) has always remained an integral and most vital function
Axis Research Mind, Nov 2011, Pages: 771
investments.
The study offers profitable investment strategies for R&D organizations, pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more
Business Insights, April 2010, Pages: 178
failure in last stage clinical trials
Case 1: Vicriviroc - Merck
Case 2: Flurizon – Myriad Pharmaceutical
Technologies influencing drug success ratio
Genomics
Proteomics
Pharmacogenomics
GBI Research, June 2011, Pages: 93
companies to invest in information technology solutions. Pharmaceutical companies have found that experimental techniques are costly, time-consuming, and involve the use of large numbers of animals
Axis Research Mind, Nov 2011, Pages: 730
for life science and as well as healthcare sector investments.
The study offers profitable investment strategies for R&D organizations, pharmaceutical manufacturers, biotechnology companies, laboratories
Axis Research Mind, Nov 2011, Pages: 656
business intelligence for life science and as well as healthcare sector investments. The study offers profitable investment strategies for R&D organizations, pharmaceutical manufacturers, biotechnology
Frost & Sullivan, Dec 2008, Pages: 98
for ‘blockbuster’ drugs are altering the landscape of pharmaceutical science. Factors such as the Human Genome Project, combinatorial chemistry, ongoing merger and acquisition (M&A) activity and partnerships between
Global Industry Analysts, Inc., Aug 2011, Pages: 630
of major biotechnology and pharmaceutical companies.
Drug Discovery firms are investing huge sums into HTS technology, providing a tremendous boost to the market and leading to simultaneous development
Decision Resources, Inc., Dec 2009, Pages: 34
, such as Genentech/Roche/Chugai’s Herceptin for breast cancer and Novartis’s Gleevec for chronic myelogenous leukemia?
- Merck & Co., Eli Lilly, Novartis, Roche, and Pfizer are examples of pharmaceutical companies
